Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Biomacromolecules ; 19(6): 2182-2193, 2018 06 11.
Article in English | MEDLINE | ID: mdl-29669209

ABSTRACT

Reactive oxygen species (ROS)-responsive polymers have attracted attention for their potential in photodynamic therapy. Herein, we report the ROS-responsive aliphatic polycarbonates prepared by the ring-opening polymerization (ROP) of three six-membered cyclic carbonate monomers with ethyl selenide, phenyl selenide or ethyl telluride groups. Under catalysis of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), all three monomers underwent the controlled anionic ROP, showing a feature of equilibrium polymerization due to the bulky effect of 5,5-disubstituents. With PEG macroinitiator, three series amphiphilic block copolymers were prepared. They could form spherical nanoparticles of ∼100 nm, which were stable in neutral phosphate buffer but dissociated rapidly under triggering of H2O2. We studied the H2O2-induced oxidation profiles of selenide- or telluride-containing small molecules by 1H NMR and revealed the factors that affect the oxidation kinetics and products. On this basis, the oxidative degradation mechanism of the copolymer nanoparticles has been clarified. Under the same oxidative condition, the telluride-containing nanoparticle degraded with the fastest rate while the phenyl selenide-based one degraded most slowly. These ROS-responsive nanoparticles could load photosensitizer chlorin e6 (Ce6) and anticancer drug doxorubicin (DOX). Under red light irradiation, Ce6-sensitized production of 1O2 that triggered the degradation of nanoparticles, resulting in an accelerated payload release. In vitro cytotoxicity assays demonstrate that the nanoparticles coloaded with DOX and Ce6 exhibited a synergistic cell-killing effect to MCF-7 cells, representing a novel responsive nanoplatform for PDT and/or chemotherapy.


Subject(s)
Hydrogen Peroxide , Nanoparticles , Neoplasms/drug therapy , Photochemotherapy , Polycarboxylate Cement , Chlorophyllides , Doxorubicin/chemistry , Doxorubicin/pharmacokinetics , Doxorubicin/pharmacology , Humans , Hydrogen Peroxide/chemistry , Hydrogen Peroxide/pharmacokinetics , Hydrogen Peroxide/pharmacology , MCF-7 Cells , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Neoplasms/metabolism , Neoplasms/pathology , Polycarboxylate Cement/chemistry , Polycarboxylate Cement/pharmacokinetics , Polycarboxylate Cement/pharmacology , Porphyrins/chemistry , Porphyrins/pharmacokinetics , Porphyrins/pharmacology
2.
Biomacromolecules ; 19(6): 2137-2145, 2018 06 11.
Article in English | MEDLINE | ID: mdl-29669212

ABSTRACT

The degradation behaviors including oxidation and hydrolysis of silicone modified polycarbonate urethanes were thoroughly investigated. These polyurethanes were based on polyhexamethylene carbonate (PHMC)/polydimethylsiloxane (PDMS) mixed macrodiols with molar ratio of PDMS ranging from 5% to 30%. It was proved that PDMS tended to migrate toward surface and even a small amount of PDMS could form a silicone-like surface. Macrophages-mediated oxidation process indicated that the PDMS surface layer was desirable to protect the fragile soft PHMC from the attack of degradative species. Hydrolysis process was probed in detail after immersing in boiling buffered water using combined analytical tools. Hydrolytically stable PDMS could act as protective shields for the bulk to hinder the chain scission of polycarbonate carbonyls whereas the hydrolysis of urethane linkages was less affected. Although the promoted phase separation at higher PDMS fractions lead to possible physical defects and mechanical compromise after degradation, simultaneously enhanced oxidation and hydrolysis resistance could be achieved for the polyurethanes with proper PDMS incorporation.


Subject(s)
Dimethylpolysiloxanes , Macrophages/metabolism , Polycarboxylate Cement , Polyesters , Polyurethanes , Animals , Dimethylpolysiloxanes/pharmacokinetics , Dimethylpolysiloxanes/pharmacology , Hydrolysis , Macrophages/cytology , Mice , Oxidation-Reduction , Polycarboxylate Cement/chemistry , Polycarboxylate Cement/pharmacokinetics , Polycarboxylate Cement/pharmacology , Polyesters/chemistry , Polyesters/pharmacokinetics , Polyesters/pharmacology , Polyurethanes/chemistry , Polyurethanes/pharmacokinetics , Polyurethanes/pharmacology , RAW 264.7 Cells
3.
Bioconjug Chem ; 27(9): 2214-23, 2016 09 21.
Article in English | MEDLINE | ID: mdl-27548011

ABSTRACT

Carboranes with rich boron content have showed significant applications in the field of boron neutron capture therapy. Biodegradable derivatives of carborane-conjugated polymers with well-defined structure and tunable loading of boron atoms are far less explored. Herein, a new family of amphiphilic carborane-conjugated polycarbonates was synthesized by ring-opening polymerization of a carborane-installed cyclic carbonate monomer. Catalyzed by TBD from a poly(ethylene glycol) macroinitiator, the polymerization proceeded to relatively high conversions (>65%), with low polydispersity in a certain range of molecular weight. The boron content was readily tuned by the feed ratio of the monomer and initiator. The resultant amphiphilic polycarbonates self-assembled in water into spherical nanoparticles of different sizes depending on the hydrophilic-to-hydrophobic ratio. It was demonstrated that larger nanoparticles (PN150) were more easily subjected to protein adsorption and captured by the liver, and smaller nanoparticles (PN50) were more likely to enter cancer cells and accumulate at the tumor site. PN50 with thermal neutron irradiation exhibited the highest therapeutic efficacy in vivo. The new synthetic method utilizing amphiphilic biodegradable boron-enriched polymers is useful for developing more-selective and -effective boron delivery systems for BNCT.


Subject(s)
Boranes/chemistry , Boron Neutron Capture Therapy/methods , Carbonates/chemistry , Hydrophobic and Hydrophilic Interactions , Polycarboxylate Cement/chemistry , Polycarboxylate Cement/therapeutic use , Animals , Biological Transport , Cell Line, Tumor , Humans , Mice , Nanoparticles/chemistry , Particle Size , Polycarboxylate Cement/metabolism , Polycarboxylate Cement/pharmacokinetics , Tissue Distribution
4.
Int J Nanomedicine ; 7: 497-510, 2012.
Article in English | MEDLINE | ID: mdl-22334780

ABSTRACT

BACKGROUND: Advances in biomedical nanotechnology raise hopes in patient populations but may also raise questions regarding biodistribution and biocompatibility, especially during pregnancy. Special consideration must be given to the placenta as a biological barrier because a pregnant woman's exposure to nanoparticles could have significant effects on the fetus developing in the womb. Therefore, the purpose of this study is to optimize an in vitro model for characterizing the transport of nanoparticles across human placental trophoblast cells. METHODS: The growth of BeWo (clone b30) human placental choriocarcinoma cells for nanoparticle transport studies was characterized in terms of optimized Transwell(®) insert type and pore size, the investigation of barrier properties by transmission electron microscopy, tight junction staining, transepithelial electrical resistance, and fluorescein sodium transport. Following the determination of nontoxic concentrations of fluorescent polystyrene nanoparticles, the cellular uptake and transport of 50 nm and 100 nm diameter particles was measured using the in vitro BeWo cell model. RESULTS: Particle size measurements, fluorescence readings, and confocal microscopy indicated both cellular uptake of the fluorescent polystyrene nanoparticles and the transcellular transport of these particles from the apical (maternal) to the basolateral (fetal) compartment. Over the course of 24 hours, the apparent permeability across BeWo cells grown on polycarbonate membranes (3.0 µm pore size) was four times higher for the 50 nm particles compared with the 100 nm particles. CONCLUSION: The BeWo cell line has been optimized and shown to be a valid in vitro model for studying the transplacental transport of nanoparticles. Fluorescent polystyrene nanoparticle transport was size-dependent, as smaller particles reached the basal (fetal) compartment at a higher rate.


Subject(s)
Fluorescent Dyes/pharmacokinetics , Nanoparticles/chemistry , Placenta/metabolism , Transcytosis/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Choriocarcinoma/metabolism , Female , Fluorescent Dyes/chemistry , Fluorescent Dyes/pharmacology , Humans , Membrane Proteins/metabolism , Particle Size , Permeability , Phosphoproteins/metabolism , Placenta/cytology , Polycarboxylate Cement/chemistry , Polycarboxylate Cement/pharmacokinetics , Polyesters/chemistry , Polyesters/pharmacokinetics , Porosity , Pregnancy , Reproducibility of Results , Uterine Neoplasms/metabolism , Zonula Occludens-1 Protein
5.
J Mater Sci Mater Med ; 21(4): 1249-53, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19967407

ABSTRACT

The potential of employing zinc polycarboxylate dental cement as a controlled release material has been studied. Benzalkonium chloride was used as the active ingredient, and incorporated at concentrations of 1, 2 and 3% by mass within the cement. At these levels, there was no observable effect on the speed of setting. Release was followed using an ion-selective electrode to determine changes in chloride ion concentration with time. This technique showed that the additive was released when the cured cement was placed in water, with release occurring by a diffusion mechanism for the first 3 h, but continuing beyond that for up to 1 week. Diffusion coefficients were in the range 5.62 x 10(-6) cm(2) s(-1) (for 1% concentration) to 10.90 x 10(-6) cm(2) s(-1) (for 3% concentration). Up to 3% of the total loading of benzalkonium chloride was released from the zinc polycarboxylate after a week, which is similar to that found in previous studies with glass-ionomer cement. It is concluded that zinc polycarboxylate cement is capable of acting as a useful material for the controlled release of active organic compounds.


Subject(s)
Cariostatic Agents/administration & dosage , Dental Cements , Polycarboxylate Cement , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/chemistry , Anti-Infective Agents, Local/pharmacokinetics , Benzalkonium Compounds/administration & dosage , Benzalkonium Compounds/chemistry , Benzalkonium Compounds/pharmacokinetics , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacokinetics , Cariostatic Agents/pharmacokinetics , Concept Formation , Delayed-Action Preparations/chemical synthesis , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Dental Cements/chemical synthesis , Dental Cements/chemistry , Dental Cements/pharmacokinetics , Dental Stress Analysis , Glass Ionomer Cements/chemistry , Glass Ionomer Cements/pharmacokinetics , Materials Testing , Models, Biological , Polycarboxylate Cement/chemical synthesis , Polycarboxylate Cement/chemistry , Polycarboxylate Cement/pharmacokinetics
6.
J Control Release ; 79(1-3): 71-9, 2002 Feb 19.
Article in English | MEDLINE | ID: mdl-11853919

ABSTRACT

A floating type dosage form (FDF) of piroxicam in hollow polycarbonate (PC) microspheres capable of floating on simulated gastric and intestinal fluids was prepared by a solvent evaporation technique. Incorporation efficiencies of over 95% were achieved for the encapsulation. In vitro release of piroxicam from PC microspheres into simulated gastric fluid at 37 degree C showed no significant burst effect. The amount released increased with time for about 8 h after which very little was found to be released up to 24 h. In intestinal fluid, the release was faster and continuous and at high drug payloads, the cumulative release reached above 90% in about 8 h. In vivo evaluation of different dosage forms of piroxicam such as free drug, drug-encapsulated microspheres and microspheres along with a loading dose of free drug in rabbits showed multiple peaking in the plasma concentration-time curve suggesting enterohepatic recirculation of the drug. Pharmacokinetic analysis showed that the bioavailability from PC microspheres alone was about 1.4 times that of the free drug and it was about 4.8 times for the dosage form consisting of the microspheres plus the loading dose. The elimination half life was increased by about three times for the microsphere preparation alone and nearly about six times for the dosage form comprising of microspheres and a loading dose in comparison to the free drug. Data obtained in this study demonstrated that FDF of piroxicam in PC microspheres was capable of sustained delivery of the drug for longer periods with increased bioavailability.


Subject(s)
Piroxicam/administration & dosage , Polycarboxylate Cement/pharmacology , Administration, Oral , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Delayed-Action Preparations , Drug Carriers/administration & dosage , Drug Carriers/pharmacokinetics , Drug Evaluation, Preclinical/methods , Gastric Mucosa/metabolism , Intestinal Mucosa/metabolism , Male , Microscopy, Electron, Scanning , Microspheres , Piroxicam/pharmacokinetics , Polycarboxylate Cement/pharmacokinetics , Rabbits
7.
Folia Med (Plovdiv) ; 42(2): 61-4, 2000.
Article in English | MEDLINE | ID: mdl-11217288

ABSTRACT

Release of potassium and nitrate ions from polycarboxylate-cement blocks containing 5% KNO3, with different exposure in extragent aqua redestillata was studied. Using flame photometry we found increased concentration of eliminated potassium ions into the extragent after the 24th hour (0.90 +/- 0.03 mg/cm3) while the maximum quantity of released potassium ions was measured after the 14th day (336 h)--1.50 +/- 0.02 mg/cm3 (t = 60, P < 0.001). The concentration of the released nitrate ions was determined by spectrophotometry at l = 410 nm. The degree of extraction of nitrate ions from the model cement blocks progressively increased with time, but their concentration in the cement decreased after the 14th day too, demonstrating a statistically significant difference: from 4.50 mg on the 20th minute to 2.60 mg on the 14th day (t = 115, P < 0.001).


Subject(s)
Nitrates/pharmacokinetics , Polycarboxylate Cement/pharmacokinetics , Potassium Compounds/pharmacokinetics , Humans , In Vitro Techniques , Ions , Potassium/pharmacokinetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...